Success Story: Finding the Hidden Drivers of Cancer Outcomes, NIW Approved in 30 Days
Client’s Testimonial:
“I truly appreciate all your help and support throughout this process.”
On January 30th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Associate II in the Field of Cancer Epidemiology (Approval Notice).
General Field: Cancer Epidemiology
Position at the Time of Case Filing: Research Associate II
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: January 30th, 2026
Processing Time: 30 days (Premium Processing Requested)
Case Summary:
Cancer outcomes in the United States are shaped by where people live, how early they are screened, whether follow-up happens on time, and how health systems allocate resources to prevention and survivorship. Those differences are measurable, but only if the data are assembled correctly and analyzed with methods that can separate signal from noise.
This NIW case featured a cancer epidemiology researcher whose work does exactly that: using large-scale population datasets, cancer registries, and modern modeling tools, including AI, to identify the healthcare and biological determinants of cancer outcomes and disparities and translate those findings into evidence that supports prevention, early detection, and survivorship care.
Turning Registries Into Decisions
Cancer registries and population datasets can tell a powerful story, but they do not speak for themselves. The client’s proposed endeavor centers on building the statistical and computational “glue” that connects real-world data to real-world decisions: identifying which factors predict worse outcomes, which barriers drive delayed diagnosis, and which gaps in care are likely to widen disparities over time.
A Research Profile Built Around Methods That Scale
The client holds an M.P.H. and has documented her work in 10 peer-reviewed journal articles and 2 conference abstracts, with 125 citations. This record supported a key idea in the petition: the client’s work is designed to scale because the same rigorous modeling frameworks can be applied across cancer types, populations, and care settings.
The record also reflected professional engagement through peer review activity (1 review), reinforcing participation in the research community’s quality-control process.
Why Speed Was Possible
This case was approved in 30 days under Premium Processing. The petition kept the story tight: what the client does, why it matters nationally, and how the evidence already shows momentum. North America Immigration Law Group (Chen Immigration Law Associates) helped present the endeavor as a public-health analytics capability, one that supports earlier detection strategies, better-targeted prevention, and more informed survivorship planning for the U.S. population.
The Outcome
The approval marked a strong result for a case built on population-level evidence generation and the practical use of data science to reduce cancer outcome gaps.